Tomasz M. Stępkowski

Dr. Tomasz M. Stępkowski

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2011 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
TSTomasz M. Stępkowski
Tomasz M. Stępkowski
Marcin KruszewskiMarcin Kruszewski
Marcin Kruszewski

1 June 2016 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
Hanna LewandowskaHanna Lewandowska
Hanna Lewandowska
Monika KalinowskaMonika Kalinowska
Monika Kalinowska
WLWlodzimierz Lewandowski
Wlodzimierz Lewandowski
TSTomasz M. Stępkowski
Tomasz M. Stępkowski
KBKamil Brzóska
Kamil Brzóska

1 January 2011
Verified
Book Chapter
Closed access
Marcin KruszewskiMarcin Kruszewski
Marcin Kruszewski
KBKamil Brzóska
Kamil Brzóska
GBGunnar Brunborg
Gunnar Brunborg
NANana Asare
Nana Asare
MDMałgorzata Dobrzyńska
Małgorzata Dobrzyńska
MRMagne Refsnes
Magne Refsnes

11 July 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
MKMinji Kim
Minji Kim
RSRemigiusz A. Serwa
Remigiusz A. Serwa
LSLukasz Samluk
Lukasz Samluk
ISIda Suppanz
Ida Suppanz
AKAgata Kodroń
Agata Kodroń
Agnieszka ChacinskaAgnieszka Chacinska
Agnieszka Chacinska
Perturbed cellular protein homeostasis (proteostasis) and mitochondrial dysfunction play an important role in neurodegenerative diseases, however, the interplay between these two phenomena remains unclear. Mitochondrial dysfunction leads to a delay in mitochondrial protein import, causing accumulation of non-imported mitochondrial proteins in the cytosol and challenging proteostasis. Cells respond by increasing proteasome activity and molecular chaperones in yeast andC. elegans. Here, we demonstrate that in human cells mitochondrial dysfunction leads to the upregulation of a chaperone HSPB1 and, interestingly, an immunoproteasome-specific subunit PSMB9. Moreover, PSMB9 expression is dependent on the translation elongation factor EEF1A2. These mechanisms constitute a defense response to preserve cellular proteostasis under mitochondrial stress. Our findings define a mode of proteasomal activation through the change in proteasome composition driven by EEF1A2 and its spatial regulation, and are useful to formulate therapies to prevent neurodegenerative diseases.


1 December 2016 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
Katarzyna DziendzikowskaKatarzyna Dziendzikowska
Katarzyna Dziendzikowska
AKAgata Krawczyńska
Agata Krawczyńska
Michał OczkowskiMichał Oczkowski
Michał Oczkowski
TKTomasz Królikowski
Tomasz Królikowski
KBKamil Brzóska
Kamil Brzóska
Joanna Gromadzka-OstrowskaJoanna Gromadzka-Ostrowska
Joanna Gromadzka-Ostrowska